Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Top Cited Papers
- 25 February 2012
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 97 (1) , 1-13
- https://doi.org/10.1016/j.pneurobio.2012.02.002
Abstract
No abstract availableKeywords
This publication has 187 references indexed in Scilit:
- Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive DeclineThe American Journal of Pathology, 2011
- 5-HT1A receptor-regulated signal transduction pathways in brainCellular Signalling, 2010
- Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's diseaseNeuroImage, 2010
- Astrocytic β2-adrenergic receptors: From physiology to pathologyProgress in Neurobiology, 2010
- Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's diseaseBrain Research, 2009
- Are dopaminergic pathways involved in theory of mind? A study in Parkinson's diseaseNeuropsychologia, 2009
- Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's diseaseNeurobiology of Aging, 2008
- Polymorphisms at the β2-adrenergic receptor gene influence Alzheimer's disease susceptibilityBrain Research, 2008
- A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP AccumulationBiochemical and Biophysical Research Communications, 1993
- Loss of high-affinity α2-adrenoceptors in Alzheimer's disease: An autoradiographic study in frontal cortex and hippocampusNeuroscience Letters, 1992